April 8, 2021 07:27 AM EDTUpdated 11:20 AM

Covid-19 roundup: BeiGene's repurposed BTK inhibitor flops in PhII trial; Philippines suspends AstraZeneca's vaccine after EMA draws link to blood clots

Another repurposed Covid-19 treatment bites the dust.

BeiGene put out word on Thursday that Brukinsa, its mantle cell lymphoma drug,

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: BeiGene's re­pur­posed BTK in­hibitor flops in PhII tri­al; Philip­pines sus­pends As­traZeneca's vac­cine af­ter EMA draws link to blood clots